CD79A and laryngeal squamous cell carcinoma: NPC cases and matched laryngeal squamous cell carcinomas (LSCC) from the Head and Neck 5000 study were characterized for their IgA and IgG antibody levels against 13 EBV antigens in a Duplex assay design.